Please use this identifier to cite or link to this item:
Title: Evaluation of liposomal bismuth-ethanedithiol-tobramycin for treatment of cystic fibrosis pulmonary pseudomonas aeruginosa infection
Authors: Alhariri, Moayad Abdulaziz I.
Keywords: Cystic fibrosis;Liposomes;Aminoglycosides;Bacteria
Issue Date: 8-Oct-2013
Publisher: Laurentian University of Sudbury
Abstract: The effectiveness of liposomes incorporating bismuth-ethanedithiol and loaded with tobramycin (LipoBiEDT-TOB) at sub-inhibitory concentrations to inhibit the production of quorum sensing signaling molecules and virulence factors induced by P. aeruginosa was evaluated in vitro. In addition, we evaluated the efficacy and safety of free and encapsulated tobramycin in liposomal formulations administered intratracheally to rats chronically infected with P. aeruginosa. LipoBiEDT-TOB significantly reduced the production of quorum sensing signaling molecules and virulence factor secretion compared to free tobramycin. The LipoBiEDT-TOB formulation significantly reduced the bacterial count in lungs, modulated the IL-8 level in blood and minimized the nephrotoxicity that is associated with aminoglycoside treatment. These results support the hypothesis that aerosolization of liposomal aminoglycosides may enhance the management of chronic lung infections caused by resistant P. aeruginosa in patients with cystic fibrosis.
Appears in Collections:Chemical Sciences - Master's Theses
Master's Theses

Files in This Item:
File Description SizeFormat 
Alhariri_Moayad_Master_Thesis.pdf1.71 MBAdobe PDFThumbnail

Items in LU|ZONE|UL are protected by copyright, with all rights reserved, unless otherwise indicated.